Utilizing bioassay- and TLC-guided column chromatography, fifteen secondary metabolites from <i>Populus alba</i> and eight compounds from <i>Salix subserrata</i> were isolated, including a novel plant metabolite salicyl ether and characterized using ultralviolet light (UV) absorbance, mass spectrometry (MS), <sup>1</sup>H-, <sup>13</sup>C-NMR (nuclear magnetic resonance), heteronuclear single quantum coherence spectroscopy (HSQC) and heteronuclear multiple bond correlation (HMBC). The extracts, their sub-fractions and the isolated compounds exhibited promising antioxidant activities in vitro in DPPH and FRAP assays. Also, the extracts of <i>P. alba</i> leaf (PL), shoots (PS), and <i>S. subserrata</i> leaf (SL) demonstrated substantial antioxidant activities in vivo in the multicellular model organism <i>Caenorhabditis elegans</i>. For the first time, the isolated secondary metabolites, aromadendrin, tremuloidin, salicin, isorhamnetin-3-<i>O</i>--d-rutinoside, gallocatechin, triandrin, and chrysoeriol-7-<i>O</i>-glucuronide were investigated. They exhibited substantial antioxidant activities in vivo. Salicin, isorhamnetin-3-<i>O</i>--d-rutinoside and gallocatechin, in particular, protected the worms against a lethal dose of the pro-oxidant juglone (80 M), decreased the endogenous reactive oxygen species (ROS) level to 45.34%, 47.31%, 68.09% and reduced juglone- induced
hsp-16.2::GFP (green fluorescence protein) expression to 79.62%, 70.17%, 26.77%, respectively. However, only gallocatechin induced higher levels of
sod-3 expression. These findings support the traditional use of <i>Populus alba</i> and <i>Salix subserrata</i> for treating inflammation especially when ROS are involved.